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Summary: We evaluated a new, fast, quantitative, turbidimetric assay (TurbiTimeSystem, Behringwerke AG, Mar-
burg, Germany) for the determination of myoglobin concentration in serum. Within-run imprecision (n = 10) was
< 3.7% in controls ranging from 81.1 to 621.4 g/l and between-day imprecision (n = 50) was < 6% in controls
ranging from 69.5 to 623.4 g/l. The assay is linear over the measuring ränge and interfering substances such äs
bilirübin, haemoglobin or haptoglobin do not interfere but triacylglycerol-rich samples are only measureable after
brief ultracentrifugation. EDTA- or citrate-treated samples display depressed myoglobin concentration when com-
pared with serum samples. The upper reference limit for apparently healthy individuals (n = 100, 50 female and
50 male) is 61.5 g/l. Comparison with nephelometry revealed a good correlation (r = 0.982) between the two
methods with the regression equation: turbidimetric assay = 5.53 4- 1.02x nephelometric assay.
Serial determination of myoglobin concentration and creatine kinase in 18 patients with proven acute myocardial
infarction showed in general an equal diagnostic significance for both analytes. In the first 4 hours after onset of
ehest pain, the determination of myoglobin can have an advantage, since it is released into the blood stream at an
earlier stage, but thereafter myoglobin can lead to false negative diagnosis. Therefore, determination of creatine
kinase and its isoenzyme MB is still the diagnostic strategy of choice in the diagnosis of acute myocardial infarction.
Introduction nosis of acute myocardial infarction (6). In the routine
clinical chemistry laboratory, myoglobin concentrations
Myoglobin is a low-molecular mass, oxygen-binding
 can be determined by radioimmunoassay (7, 8) or im-
haemoprotein (Mr 17700) of the skeletal and cardiac munonephelometry (9). ^  methods m sensitive but
muscle (1). Elevation of the myoglobin concentration
 time consuming and not suitable for emergency testing.
above the upper reference limit is normally caused by
 A latox agglutination assay (5> 10) gives only semi-
the injury of cardiac muscle, e. g. acute myocardial m-
 quantitative results and is less sensitive. The aim of our
farction, provided skeletal muscle has been excluded äs
 study was to evaluate a new fast ^  quantitative turbidi-
a sotirce. In addition, physical exercise (2) or decreased
 metric assay for determination of myoglobin and to
renal function with subsequent decreased myoglobin
 test the diagilostic relevance in the early phase of acute
clearance can result in elevated myoglobin levels in
 myocardjai infarction.
blood (3). After aoute myocardial infarction, myoglobin
is rapidly released from necrotic myocardium in ad-
vance of cytoplasmic enzymes such äs creatine kinase
 (
(EC 2.7.3.2)1) or its isoenzyme creatine kinase-MB1) (4, Creatine"kinase EC 2.7.3.2
5). Therefore, myoglobin can be used for the early diag- Creatine kinase-MB
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Materials and Methods
.Refcrence i n d i v i d u a l s and pat ients
Sera vvere obtained from
- 100 patients vvith elevated creatine kinase levels; reference lim-
its in this laboratory are 80 U/l for male and 70 U/l for fe-
male(l l) ,
- 100 apparently healthy persons (50 males and 50 females) to
determine the reference interval.
- 18 patients with acute myocardial infarction (at admission and
at defmite times after onset of ehest pain); acute myocardial
infarction was confirmed with typical changes in ECG and
courses of creatine kinase and creatine kinase-MB.
Furthermore, two plasma samples with K-ethylenediaminetetraace-
tate (EDTA) and Na-citrate s an anticoagulant were collected from
20 individuals.
All specimens were analysed within 24 hours after venipuncture.
The specimens from the 18 patients with acute myocardial infarc-
tion were stored at -20 °C until analysis.
Immuno tu rb id ime t r i c method
The determination of serum and plasma myogiobin was performed
using the TurbiTimeSystem (Behringwerke AG, Marburg, Ger-
many), a turbidimetric immunoassay for the single testing of
plasma proteins. The calibration Information needed for the assay
is charge-dependent and inserted s a bar code in the package Infor-
mation. For measurement of myogiobin, a cuvette is filled with
50 μΐ of undiluted serum or plasma, inserted into the System, and
500 μΐ reagent solution (Turbiquant Myogiobin, code No. QWNK,
Behringwerke AG) is added. The test result is presented within 2
minutes. The pre-programmed measuring r nge lies between 50
and 650 μg/l.
Immunonephelometr ic method
The BNA System (Behringwerke AG) is a fully automated System
for immunonephelometric examination of plasma proteins. Myo-
giobin measurement is carried out with latex particles coated with
anti-myoglobin antibodies (NA-Latex Myogiobin Test, Beh-
ringwerke AG) (9). The measuring r nge extends frorn 21.9 to 350
μg/l with a coefficient of Variation of 10% at 100 μg/l.
Creatine kinase and creatine kinase-MB
Creatine kinase and creatine kinase-MB were determined using
dry-film technology on a fully automated analyser (Ektachem
700XR, Eastman Kodak, Rochester, NY). The coefficients of Varia-
tion were 4.1% for creatine kinase at 100 U/l and 4.9% for creatine
kinase-MB at 36 U/l.
Evaluation
Evaluation was performed according the recommendations of
Singer et al. (12). All measurements were performed in duplicate.
Statistical analysis
Correlations were calculated by linear regression analysis.
Results
Imprecision
Three different pooled human sera with elevated myo-°
globin concentrations and a commercial control serum
Tab. l Within-run and between-day imprecision of the turbidi-
metric determination of myogiobin concentration.
Control
sample
Intra-assay imprecision:
Myogiobin, * (μ§/1) 101.8
Myogiobin, s ^ g/l) 3.74
CV (%) 3.69
n 10
Serum
pool i
81.1
2.4
2.96
10
Serum
pool II
160.3
2.83
1.76
10
Serum
pool III
621.4
14
2.25
10
Inter-assay imprecision:
Myogiobin, χ (μ^Ι)
Myogiobin, s ι
CV (%)
98.6
2.99
3.03
52
69.5
4.16
5.99
51
154.5
5.95
3.85
52
623.4
17.3
2.77
52
(Behringwerke AG, Marburg, Gennany) were analysed
10 times to estimate intra-assay imprecision (tab. 1). For
inter-assay reproducibility all controls were tested over
50 coiisecutive days (tab. 1).
Linearity
The linearity of dilution was investigated using serum
samples containing high myogiobin concentrations. Se-
ri l dilutions (10+0, 9+1, ..., 0+10) were made with
NaCl or enzyme diluent. Figure l shows the res lts of
serial dilution of one of these serum samples. After cor-
rection of the measured value for the dilution factor,
recovery was found to be between 81 and 101% using
NaCl, and 88 and 101% using enzyme diluent to dilute
the myogiobin conceritration of undiluted samples
(tab. 2).
Interfering s bstances
Sera containing potential interfering s bstances were
added to myoglobin-rich serum samples in different ra-
1.00 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0
Fraction of str m in the sample
Fig. l Linearity of dilution. X-axis shows the fraction of serum,
(·—·) dilution with enzyme diluent, (·—·) with NaCl s a dilu-
ent for one exemplary serum. t
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Tab. 2 Dilution of myoglobin-containing serum samplcs with en-
zyme diluent and NaCl. Shown is the percentual deviation from
the theoretical value for every dilution Step.
Myoglobin recovery (% ± s)
Diluent Diluent
sample -f diluent NaCl
9 +
8 +
7 +
6 +
5 +
4 +
3 +
2 +
1 +
i
2
3
4
5
6
7
8
9
100.75
98.5
97
97
89.75
89.75
86.5
81
—
± 0.96
± 1.7
± 1.4
± 6.2
± 3.86
± 1.26
± 3.4
± 2.83
—
Enzyme
100.75
99.25
97.75
97.25
95.25
92
88.5
92.25
100
(n = 2)
diluent
± 1.5
±4.3
± 0.96
± 1.26
± 2.63
± 1.83
± 3.7
± 4.7
± 4.24
tios (10+0, 9+1, ..., 04-10). No interferences were
shown with bilirubin, haemoglobin and haptoglobin at
final concentrations of 2, 30 and 7000 mg/1 respectively.
The concentration of myoglobin in serum that was en-
riched with triacylglycerol could not be determined.
However, after brief ultracentrifugation (5 min,
240 000 g) no interferences were found (fig. 2).
Effect of probe
Figure 3 shows the comparison of serum vs. EDTA- and
citrate-plasma. In both plasmas, the amount of myoglo-
bin measured is less than that found in serum; the EDTA
plasma showed only 92% of the actual myoglobin con-
centration, and the citrate plasma 89%.
0.10 0.20 i0.30 0.40 0.50 0.60 0.70 0.80 0.90 1.00
Fraction of str m in the sample
Fig. 2 Effect of potential interfering substances. X-axis shows the
fraction of serum, (+ — 4) dilution with bilirubin-containing se-
rum» (D—D) dilutioh with haemolytic serum, (β-—·) dilution with
haptogl bin-rich serum, (·—·) dilution with triacylglycerol-rich
serum after brief ultracentrifugation.
Serum EDTA plasma Citrate plasma
Fig. 3 Comparison of myoglobin results in serum, EDTA- and
citrate-plasma in 20 patients. The corresponding samples are con-
nected by lines. Apparent myoglobin concentration is depressed in
plasma in contrast to serum samples.
Tab. 3 Stability of myoglobin in serum in dependence on temper-
ature and time.
Myoglobin ^g/l)
Sample
l
2
3
4
5
6
7
8
9
10
Actual
value
490
103.5
358.5
362.5
69.3
179.5
226
263
320
492
+20 °C
(2 days)
478.5
99.25
348.5
342.5
60.75
159
203
295.5
312
488.5
+4°C
(1 week)
461
104.5
372.5
354
69.25
169.5
210.5
288
311
505
-20 °C
(2 weeks)
490.5
107.5
354.5
357
74
166
224.5
289
311
491
-20 °C
(3 months)
458
110.5
334.5
352
68.4
162.5
236.5
288.5
302
485.5
Stability
Ten serum samples were divided into aliquots and stored
either at room temperature for 2 days, at H-4 °C for one
week or at —20 °C at least 3 months. In contrast to fresh
samples, no alteration in myoglobin concentration was
found (tab. 3).
Reference values
Figure 4 shows the cumulative distribution of the myo-
globin concentration in the serum samples of the refer-
ence population. The upper reference limit (97.5% per-
centile) was found to be 61.5 μ§/1, and the maximum
value was 159 μg/L
Method comparison
Ninety-one serum samples with myoglobin concentra-
tions between 50 and 650 Mg/1 in the immunoturbidimet-
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Fig. 4 Distribution of myoglobin concentration in apparently
healthy individuals (50 females and 50 males). Bars show the per-
centual, filled squares the cumulative portion of the total number.
Fig. 5 Comparison of rayoglobin concentration in serum deter-
mined by immunonephelometry and immunoturbidimetry. A good
correlation was found: (y = 1.02x H- 5.53, r = 0.982).
10000
10
10 15 20 25 30 35 40 45 50 55
Time after onsct of ehest pain [h)
60
Fig. 6 Time courses of creatine kianse activity in 18 patients with
acute myocardial infarction.
0 5 10 15 20 25 30 35 40 45 50 55 60
Time after onsct of ehest pain [h]
Fig. 7 Time courses of myoglobin concentration in 18 patients
with acute myocardial infarction. Myoglobin concentrations below
the detection limit of the assay are set at 50 μ§/1.
ric assay were re-evaluated using immunonephelometry.
The following correlation was obtained: y=1.02x
+ 5.53, r = 0.982 (fig. 5).
Diagnostic implications
To investigate the diagnostic implication of myoglobin
determination in the early phase ofacute myocardiial in-·
farction, serum samples were collected from 18 patients
with proven acute myocardial infarction at admission
and at 2, 4, 6, 9, 12, 15, 18 and then every 6 hours for
at least 60 hours after onset of ehest pain. Myoglobin
concentration and creatine kinase activity were mea-
sured in all samples. Figure 6 and 7 summarize the time
courses of creatine kinase activity and myoglobin con-
centration of all 18 patients. Myoglobin appeared at con·?
centrations above the upper reference limit on average
2.9 ±1.7 hours after onset of ehest pain. In contrast,
creatine kinase activity above the upper reference limit
was first observed on average 5.3 ± 2 hours after acute
myocardial infarction. The peak value for myoglobin
was reached 4.8 ±3.2 hours after acute myocardial in-
farction, for creatine kinase activity at 15.2 ± 7.4 hours.
At 23.9 ± 13.8 hours after onset of ehest pain, myoglo-
bin concentration returned to within the reference in-
terval, whereby 7 patients showed a so called "staccato
phenomenon" (13). Creatine kinase activity retumed to
the normal r nge on average 51.7 ± 15.6 hours after
acute myocardial infarction, during which time six pa-
tients showed a second pe lk.
Elevated myoglobin or creatine kinase activity levels *
alone are insufficient for the diagnosis of acute myocar-
dial infarction. Therefore, it- is mecessary to determine
Eur. J. CIin: Chem. Clin. Biochem. / Vol. 32; 1994 /No. 11
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the level in a second, independent sample approximately
one hour later to confirm that it displays a significant
increase compared with the starting value. Figure 8 and
9 show creatine kinase activity and myoglobin concen-
tration in the first two blood collections for each patient.
In the first sample, the myoglobin concentration He
äbove the upper reference limit for all patients. In one
patient the second value is, however decreased com-
pared with the first. In 10 patients, both values of cre-
atine kinase activity are within the reference limit, but in
all 18 patients the second value is higher than the first.
Discussion
Evaluation
As described under results, the TurbiTimeSystem is a
fast, reliable and simple method for the quantitative de-
termination of myoglobin concentrations in serum. In-
600
soo
Ist sample 2nd sample
Fig. 8 Comparison of the creatine kinase concentrations of the
first two blood samples in all 18 patients after acute myocardial in-
farction.
10000
Ist sample 2nd sample
Fig. 9 Comparison of the myoglobin concentrations of the first
two blood samples in all 18 patients after acute myocardial infarc-
tion.
tra-assay and inter-assay imprecision is low and compa-
xability with immunonephelometry is good. With the ex-
ception of triacylglycerol, potentially interfering sub-
stances do not disturb the assay. Similar results were
obtained by Delanghe et al. (14) and Mair et al. (15),
but correlation with RIA was inferior. Lipid extraction
using an extraction agent leads to an underestimation of
myoglobin of up to 36% (14). This can be avoided using
brief ultracentrifugation.
Myoglobin levels in serum are in general higher than in
EDTA- or citrate-treated plasma samples, but the lower
results for citrate plasma are primarily dependent on the
dilution factor. Therefore, reference ranges for each type
of material are necessary. For serum myoglobin, we
found an upper reference limit of 61.5 g/l. This is in
general in agreement with the values obtained by Mair
et al. (15) who found an upper reference limit of 70
g/l and by Delanghe et al. (14) who found sex-related
reference limits of 68.6 g/l for females and 74.1 g/l
for males. In conclusion, the immunoturbidimetric deter-
mination of myoglobin is a viable alternative to other
quantitative assays. Its advantages are that it is a fast,
reliable method and thus suitable for an emergency labo-
ratory or small laboratory units.
Diagnostic significance
In the early phase of acute myocardial infarction there
are no differences in the predictive value of myoglobin
concentration or creatine kinase activity (l, 5, 8, 16). As
only a semi-quantitative latex-test for determination of
myoglobin was hitherto available (5, 10), it was not
practicable to determine myoglobin concentration in
emergency situations. The TurbiTimeSystem permits the
rapid, quantitative determination of myoglobin concen-
tration. This raises afresh the question of whether the
determination of myoglobin concentration is superior to
creatine kinase aetivity in the early phase diagnosis of
acute myocardial infarction.
Both quantities have the same tissue distribution, above
all in skeletal and cardiac muscle (l, 17). In addition,
physical exercise or disease affecting skeletal muscles
(2) äs well äs decreased renal function will lead to an
increased myoglobin concentration (3). Taking these
factors ihto consideration and the dynamics of tissue-
release and clearance, both analytes can be recruited in
the diagnosis of acute myocardial infarction.
Our findings indicate that myoglobin, in comparison
with creatine kinase, shows earlier values above the up-
per reference limit (2.9 vs. 5.3 hours) in concordance
with other data (15 a & b, 18, 19, 20). The concentration
peaks much earlier (4.8 vs. 15.2 hours) and myoglobin
returns to the normal ränge earlier than creatine kinase
Eur. J. Ciin. Chem. Clin. Biochem. / Vol. 32, 1994 / No. 11
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(23,9 vs. 51.7 hours). Because the molecular mass of
myoglobin is lower than that of creatine kinase, it ap-
pears before creatine kinase in the blood stream and is
rapidly cleared through the kidneys. On the other band,
our investigations show that creatine kinase activity
rises in all patients with acute myocardial infarction in
two consecutive blood samples, even if the second value
for creatine kinase in 10 out of 18 patient lies within the
normal ränge (flg. 7). In contrast, the second myoglobin
sample of patient even showed a decreased value
(fig. 8).
Therefore, both quantities have equal significance in the
diagnosis of acute myocardial infarction. In the first
hours after the onset of ehest pain, myoglobin has a
diagnostic advantage äs it is released into the blood
stream earlier than creatine kinase. If the first blood sam-
ple from patients with acute myocardial infarction is taken
later than 4 hours after onset of ehest pain, myoglobin can
lead to false negative diagnosis. For this reason, the simul-
taneous determination of creatine kinase and its isoen-
zyme creatine kinase-MB is still the diagnostic strategy of
choice for the diagnosis of acute myocardial infarction
(4). On the other hand, in monitoring thrombolysis ther-
apy of acute myocardial infarction, the determination of
myoglobin in superior to creatine kinase. As myoglobin
is rapidly released after successM thrombolysis into the
blood, increasing values of myoglobin show effective re-
canalisation within a few hours (20).
Recently, a new, fast system that makes use of "dry
chemistry" procedüres has been made available (OPUS,
Behringwerke AG, Marburg, Germany). Whether or not
this new technology is superior to turbidimetry äs a fast
technique for emefgency use has yet to be demonstrated.
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